Investment analysts at HC Wainwright cut their FY2026 earnings per share (EPS) estimates for Ekso Bionics in a research note ...
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Q4 2024 Earnings Call Transcript March 3, 2025 Ekso Bionics Holdings, Inc. misses ...
Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology ...
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology ...
Ekso Bionics Holdings Inc. (EKSO) reported its Q4 2024 earnings, showing a mixed financial performance. The company posted a revenue of $5.1 million, slightly below the forecast of $6.05 million, and ...
Reports Q4 revenue $5.09M, consensus $5.05M. “We are pleased to close out 2024 with record fourth quarter revenue, improved gross margin and ...
14d
Ekso Bionics Holdings Inc (EKSO) reports a 5% revenue increase and strategic alliances to enhance market access, despite challenges in reimbursement processes.
SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results